funder-graph

FundersNY

Grants paid by Cancer Research and Treatment Fund Inc

EIN 13-6272085 · New York, NY · Form 990, Schedule I

Cancer Research and Treatment Fund Inc of New York, NY (EIN 13-6272085) reported 7 grants paid totaling $2,292,050 to 2 recipients in tax years 2020–2024, on Form 990, Schedule I. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.

Grants paid

$2,292,050

7 grants

Recipients

2

distinct organizations

Tax years

2020–2024

5 filings in the corpus

By tax year

Grants by tax year, as the same figures
Tax yearGrants paidAmount paidApproved for future
20202$388,000
20211$375,000
20221$483,500
20232$524,500
20241$521,050

Top recipients

The 2 recipients receiving the most from Cancer Research and Treatment Fund Inc, by grants paid, out of 2 distinct recipients.

Recipients ranked by total grants paid
RecipientMatchLocationGrantsTotal paidLatest year
Weill Cornell Medical College 15-0532082ANew York, NY5$2,280,9502024
The Fund for Blood and Cancer 13-3064424ANew York, NY2$11,1002023

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Every grant

All 7 grant rows this organization reported, most recent first.

Grants reported by Cancer Research and Treatment Fund Inc
Tax yearRecipientMatchAmountTypePurposeSource filing
2024Weill Cornell Medical College New York, NYA$521,050paidRESEARCH- MYELOPROLIFERATIVE NEOPLA202502519349301805
2023Weill Cornell Medical College New York, NYA$519,400paidRESEARCH- MYELOPROLIFERATIVE NEOPLA202412579349301421
2023The Fund for Blood and Cancer New York, NYA$5,100paidCANCER RESEARCH202412579349301421
2022Weill Cornell Medical College New York, NYA$483,500paidRESEARCH- MYELOPROLIFERATIVE NEOPLA202312509349301026
2021Weill Cornell Medical College New York, NYA$375,000paidRESEARCH- MYELOPROLIFERATIVE NEOPLA202222699349300112
2020Weill Cornell Medical College New York, NYA$382,000paidRESEARCH- MYELOPROLIFERATIVE NEOPLA202122989349301557
2020The Fund for Blood and Cancer New York, NYA$6,000paidCANCER RESEARCH202122989349301557

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.

Source filings

Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.

Returns this page is derived from
FormTax yearPeriod endFiledSchemaIRS OBJECT_ID
99020242024-12-31not stated2024v5.2202502519349301805
99020232023-12-31not stated2023v5.1202412579349301421
99020222022-12-31not stated2022v5.0202312509349301026
99020212021-12-31not stated2021v4.0202222699349300112
99020202020-12-31not stated2020v4.0202122989349301557

Derived from IRS Form 990 e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/136272085.json.

The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.

This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.